Regulation of Jak2 function by phosphorylation of Tyr317 and Tyr637 during cytokine signaling

Molecular and Cellular Biology

Volumn 29, Issue 12, 2009, Pages 3367-3378

  Robertson, Scott A ^a   Koleva, Rositsa I ^b   Argetsinger, Lawrence S ^a   Carter Su, Christin ^a   Marto, Jarrod A ^b   Feener, Edward P ^c   Myers Jr , Martin G ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

JANUS KINASE 2;

ARTICLE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

AMINO ACID SEQUENCE; BINDING SITES; CELL LINE; CYTOKINES; FEEDBACK, PHYSIOLOGICAL; HUMANS; JANUS KINASE 2; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; TYROSINE;

EID: 67649183002     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00278-09     Document Type: Article

References (39)

1. Argetsinger, L. S., J. L. Kouadio, H. Steen, A. Stensballe, O. N. Jensen, and C. Carter-Su. 2004. Autophosphorylation of JAK2 on tyrosines 221 and 570 regulates its activity. Mol. Cell. Biol. 24:4955-4967.
2. Banks, A. S., S. M. Davis, S. H. Bates, and M. G. Myers, Jr. 2000. Activation of downstream signals by the long form of the leptin receptor. J. Biol. Chem. 275:14563-14572.
3. Baumann, H., K. K. Morella, D. W. White, M. Dembski, P. S. Bailon, H. Kim, C. F. Lai, and L. A. Tartaglia. 1996. The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proc. Natl. Acad. Sci. USA 93:8374-8378.
4. Bjorbaek, C., R. M. Buchholz, S. M. Davis, S. H. Bates, D. D. Pierroz, H. Gu, B. G. Neel, M. G. Myers, Jr., and J. S. Flier. 2001. Divergent roles of SHP-2 in ERK activation by leptin receptors. J. Biol. Chem. 276:4747-4755.
5. Bjorbaek, C., H. J. Lavery, S. H. Bates, R. K. Olson, S. M. Davis, J. S. Flier, and M. G. Myers, Jr. 2000. SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985. J. Biol. Chem. 275:40649-40657.
6. Coppari, R., M. Ichinose, C. E. Lee, A. E. Pullen, C. D. Kenny, R. A. McGovern, V. Tang, S. M. Liu, T. Ludwig, S. C. Chua, Jr., B. B. Lowell, and J. K. Elmquist. 2005. The hypothalamic arcuate nucleus: a key site for mediating leptin's effects on glucose homeostasis and locomotor activity. Cell Metab. 1:63-72. (Pubitemid 43960588)
7. Dusa, A., J. Staerk, J. Elliott, C. Pecquet, H. A. Poirel, J. A. Johnston, and S. N. Constantinescu. 2008. Substitution of pseudokinase domain residue Val-617 by large non-polar amino acids causes activation of JAK2. J. Biol. Chem. 283:12941-12948.
8. Feener, E. P., F. Rosario, S. L. Dunn, Z. Stancheva, and M. G. Myers, Jr. 2004. Tyrosine phosphorylation of Jak2 in the JH2 domain inhibits cytokine signaling. Mol. Cell. Biol. 24:4968-4978.
9. Feng, J., B. A. Witthuhn, T. Matsuda, F. Kohlhuber, I. M. Kerr, and J. N. Ihle. 1997. Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop. Mol. Cell. Biol. 17:2497-2501.
10. Flier, J. S., and E. Maratos-Flier. 1998. Obesity and the Hypothalamus: novel peptides for new pathways. Cell 92:437-440. (Pubitemid 28101107)
11. Frank, S. J., W. Yi, Y. Zhao, J. F. Goldsmith, G. Gilliland, J. Jiang, I. Sakai, and A. S. Kraft. 1995. Regions of the Jak2 tyrosine kinase required for coupling to the growth hormone receptor. J. Biol. Chem. 270:14776-14785.
12. Friedman, J. M. 2002. The function of leptin in nutrition, weight, and physiology. Nutr. Rev. 60:S1-S14.
13. Funakoshi-Tago, M., S. Pelletier, T. Matsuda, E. Parganas, and J. N. Ihle. 2006. Receptor specific downregulation of cytokine signaling by autophosphorylation in the FERM domain of Jak2. EMBO J. 25:4763-4772. (Pubitemid 44607022)
14. Funakoshi-Tago, M., S. Pelletier, H. Moritake, E. Parganas, and J. N. Ihle. 2008. Jak2 FERM domain interaction with the erythropoietin receptor regulates Jak2 kinase activity. Mol. Cell. Biol. 28:1792-1801.
15. Funakoshi-Tago, M., K. Tago, T. Kasahara, E. Parganas, and J. N. Ihle. 2008. Negative regulation of Jak2 by its auto-phosphorylation at tyrosine 913 via the Epo signaling pathway. Cell. Signal. 20:1995-2001.
16. Gadina, M., D. Hilton, J. A. Johnston, A. Morinobu, A. Lighvani, Y. J. Zhou, R. Visconti, and J. J. O'Shea. 2001. Signaling by type I and II cytokine receptors: ten years after. Curr. Opin. Immunol. 13:363-373.
17. Ghilardi, N., S. Ziegler, A. Wiestner, R. Stoffel, and R. C. Skoda. 1996. Defective STAT signaling by the leptin receptor in diabetic mice. Proc. Natl. Acad. Sci. USA 93:6231-6235.
18. Godeny, M. D., J. Sayyah, D. Vonderlinden, M. Johns, D. A. Ostrov, J. Caldwell-Busby, and P. P. Sayeski. 2006. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT(1) receptor. Cell. Signal. 19:600-609.
19. Herrington, J., and C. Carter-Su. 2001. Signaling pathways activated by the growth hormone receptor. Trends Endocrinol. Metab. 12:252-257.
20. Ihle, J. N., W. Thierfelder, S. Teglund, D. Stravapodis, D. Wang, J. Feng, and E. Parganas. 1998. Signaling by the cytokine receptor superfamily. Ann. N. Y. Acad. Sci. 865:1-9.
21. Ishida-Takahashi, R., F. Rosario, Y. Gong, K. Kopp, Z. Stancheva, X. Chen, E. P. Feener, and M. G. Myers, Jr. 2006. Phosphorylation of Jak2 on Ser(523) inhibits Jak2-dependent leptin receptor signaling. Mol. Cell. Biol. 26:4063-4073.
22. Kloek, C., A. K. Haq, S. L. Dunn, H. J. Lavery, A. S. Banks, and M. G. Myers, Jr. 2002. Regulation of Jak kinases by intracellular leptin receptor sequences. J. Biol. Chem. 277:41547-41555.
23. Kurzer, J. H., L. S. Argetsinger, Y. J. Zhou, J. L. Kouadio, J. J. O'Shea, and C. Carter-Su. 2004. Tyrosine 813 is a site of JAK2 autophosphorylation critical for activation of JAK2 by SH2-B beta. Mol. Cell. Biol. 24:4557-4570.
24. Luo, H., P. Rose, D. Barber, W. P. Hanratty, S. Lee, T. M. Roberts, A. D. D'Andrea, and C. R. Dearolf. 1997. Mutation in the Jak kinase JH2 domain hyperactivates Drosophila and mammalian Jak-Stat pathways. Mol. Cell. Biol. 17:1562-1571.
25. Matsuda, T., J. Feng, B. A. Witthuhn, Y. Sekine, and J. N. Ihle. 2004. Determination of the transphosphorylation sites of Jak2 kinase. Biochem. Biophys. Res. Commun. 325:586-594.
26. Mazurkiewicz-Munoz, A. M., L. S. Argetsinger, J. L. Kouadio, A. Stensballe, O. N. Jensen, J. M. Cline, and C. Carter-Su. 2006. Phosphorylation of JAK2 at serine 523: a negative regulator of JAK2 that is stimulated by growth hormone and epidermal growth factor. Mol. Cell. Biol. 26:4052-4062.
27. McDoom, I., X. Ma, A. Kirabo, K. Y. Lee, D. A. Ostrov, and P. P. Sayeski. 2008. Identification of tyrosine 972 as a novel site of Jak2 tyrosine kinase phosphorylation and its role in Jak2 activation. Biochemistry 47:8326-8334.
28. Morgan, K. J., and D. G. Gilliland. 2008. A role for JAK2 mutations in myeloproliferative diseases. Annu. Rev. Med. 59:213-222.
29. Myers, M. G., Jr. 2004. Leptin receptor signaling and the regulation of mammalian physiology. Recent Prog. Horm. Res. 59:287-304.
30. Ndassa, Y. M., C. Orsi, J. A. Marto, S. Chen, and M. M. Ross. 2006. Improved immobilized metal affinity chromatography for large-scale phosphoproteomics applications. J. Proteome Res. 5:2789-2799. (Pubitemid 44595179)
31. Ragimbeau, J., E. Dondi, A. Alcover, P. Eid, G. Uze, and S. Pellegrini. 2003. The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression. EMBO J. 22:537-547. (Pubitemid 36193598)
32. Saharinen, P., and O. Silvennoinen. 2002. The pseudokinase domain is required for suppression of basal activity of Jak2 and Jak3 tyrosine kinases and for cytokine-inducible activation of signal transduction. J. Biol. Chem. 277:47954-47963.
33. Shevchenko, A., M. Wilm, O. Vorm, and M. Mann. 1996. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68:850-858.
34. Tartaglia, L. A. 1997. The leptin receptor. J. Biol. Chem. 272:6093-6096.
35. Ungureanu, D., P. Saharinen, I. Junttila, D. J. Hilton, and O. Silvennoinen. 2002. Regulation of Jak2 through the ubiquitin-proteasome pathway involves phosphorylation of Jak2 on Y1007 and interaction with SOCS-1. Mol. Cell. Biol. 22:3316-3326.
36. Velazquez, L., K. E. Mogensen, G. Barbieri, M. Fellous, G. Uze, and S. Pellegrini. 1995. Distinct domains of the protein tyrosine kinase tyk2 required for binding of interferon-α/β and for signal transduction. J. Biol. Chem. 270:3327-3334.
37. Yeh, T. C., E. Dondi, G. Uze, and S. Pellegrini. 2000. A dual role for the kinase-like domain of the tyrosine kinase Tyk2 in interferon-alpha signaling. Proc. Natl. Acad. Sci. USA 97:8991-8996.
38. Zhao, Y., F. Wagner, S. J. Frank, and A. S. Kraft. 1995. The amino-terminal portion of the JAK2 protein kinase is necessary for binding and phosphorylation of the granulocyte-macrophage colony-stimulating factor receptor beta c chain. J. Biol. Chem. 270:13814-13818.
39. Zhou, Y. J., M. Chen, N. A. Cusack, L. H. Kimmel, K. S. Magnuson, J. G. Boyd, W. Lin, J. L. Roberts, A. Lengi, R. H. Buckley, R. L. Geahlen, F. Candotti, M. Gadina, P. S. Changelian, and J. J. O'Shea. 2001. Unexpected effects of FERM domain mutations on catalytic activity of Jak3: structural implication for Janus kinases. Mol. Cell 8:959-969. (Pubitemid 34031799)